A new publication discusses the role of clinical pharmacology in advancing rare disease development. It emphasizes the transition from small data sets to informed decision-making in drug development.
from small data to big decisions how clinical pharmacology shapes rare disease development
Original title: “From Small Data to Big Decisions: How Clinical Pharmacology Shapes Rare Disease Development.”